VARIANTS FGF21

• 收藏
• 分享

专利权人:

Sanofi

发明人:

申请号：

EP20150761.3

公开号：

EP3693382A1

申请日:

2016.12.02

申请国别(地区):

EP

年份:

2020

代理人:

摘要：

The present invention relates to polypeptide variants of human fibroblast growth factor 21 (FGF21) and fusion molecules thereof, as well as to nucleic acid molecules encoding the same. It further relates to their use as medicaments, in particular for the treatment of obesity, overweight, metabolic syndrome, diabetes mellitus, hyperglycemia, dyslipidemia, non-alcoholic steatohepatitis (NASH) and/or atherosclerosis.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/